162 related articles for article (PubMed ID: 3000923)
21. Polyvalent immune globulin and cytomegalovirus infection after renal transplantation.
Kasiske BL; Heim-Duthoy KL; Tortorice KL; Ney AL; Odland MD; Rao KV
Arch Intern Med; 1989 Dec; 149(12):2733-6. PubMed ID: 2556978
[TBL] [Abstract][Full Text] [Related]
22. Acute graft-vs.-host disease and interstitial pneumonitis interrelated problems following allogeneic bone marrow transplantation: effects of intravenous immune globulin and other interventions.
Champlin RE; Ho WG; Winston DJ
J Hosp Infect; 1988 Aug; 12 Suppl D():29-33. PubMed ID: 2902126
[No Abstract] [Full Text] [Related]
23. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease.
Snydman DR
Rev Infect Dis; 1990; 12 Suppl 7():S839-48. PubMed ID: 2173113
[TBL] [Abstract][Full Text] [Related]
24. CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin).
Zintl F; Färber I; Hermann J; Fuchs D; Prager J; Wutzler P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):557-64. PubMed ID: 2480308
[TBL] [Abstract][Full Text] [Related]
25. Prophylaxis of CMV infection in bone marrow transplant recipients by hyperimmune CMV gamma-globulin.
Condie RM; O'Reilly RJ
Dev Biol Stand; 1982; 52():501-13. PubMed ID: 6299859
[TBL] [Abstract][Full Text] [Related]
26. [Cytomegalovirus hyperimmune globulin and cytomegalovirus-tested blood products--a pilot study in bone marrow graft recipients].
Beelen DW; Neumann MC; Mahmoud HK; Henneberg K; Thraenhart O; Schaefer UW
Immun Infekt; 1985 Sep; 13(5):229-32. PubMed ID: 2998980
[TBL] [Abstract][Full Text] [Related]
27. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A
Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
[TBL] [Abstract][Full Text] [Related]
28. Immune globulin therapy in allogeneic bone marrow transplant: a critical review.
Guglielmo BJ; Wong-Beringer A; Linker CA
Bone Marrow Transplant; 1994 May; 13(5):499-510. PubMed ID: 8054903
[TBL] [Abstract][Full Text] [Related]
29. Prevention of early interstitial pneumonitis (IP) after BMT by exclusion of CMV-IG-POS platelet donors, prophylaxis with CMV immune globuline, and by a modified TBI regimen.
Hinterberger W; Alth G; Höcker P; Kallinger W; Kier P; Kolbabek H; Lechner K; Popov-Kraup T
Bone Marrow Transplant; 1991; 7 Suppl 2():43. PubMed ID: 1652329
[No Abstract] [Full Text] [Related]
30. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.
Sullivan KM; Kopecky KJ; Jocom J; Fisher L; Buckner CD; Meyers JD; Counts GW; Bowden RA; Peterson FB; Witherspoon RP
N Engl J Med; 1990 Sep; 323(11):705-12. PubMed ID: 2167452
[TBL] [Abstract][Full Text] [Related]
31. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G
Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for cytomegalovirus infection in BMT recipients transfused exclusively with seronegative blood products.
Rubie H; Attal M; Campardou AM; Gayet-Mengelle C; Payen C; Sanguignol F; Calot JP; Charlet JP; Robert A; Huguet F
Bone Marrow Transplant; 1993 Mar; 11(3):209-14. PubMed ID: 8385522
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.
Reusser P; Osterwalder B; Gratama JW; The TH; Gratwohl A; Speck B
Bone Marrow Transplant; 1989 May; 4(3):267-72. PubMed ID: 2543469
[TBL] [Abstract][Full Text] [Related]
34. Failure to prevent cytomegalovirus infection by cytomegalovirus hyperimmune plasma: a randomized trial by the Nordic Bone Marrow Transplantation Group.
Ringdén O; Pihlstedt P; Volin L; Nikoskelainen J; Lönnqvist B; Ruutu P; Ruutu T; Toivanen A; Wahren B
Bone Marrow Transplant; 1987 Oct; 2(3):299-305. PubMed ID: 2844340
[TBL] [Abstract][Full Text] [Related]
35. Prophylaxis and treatment of infection in the bone marrow transplant recipient.
Winston DJ
Curr Clin Top Infect Dis; 1993; 13():293-321. PubMed ID: 8397916
[TBL] [Abstract][Full Text] [Related]
36. [Serological diagnosis of cytomegalovirus-induced interstitial pneumonia in patients following bone marrow transplantation].
Müller A; Pustowoit B; Arnold U; Hoffmann FA; Kubel M; Raue I; Friedrich T
Z Gesamte Inn Med; 1991 Aug; 46(12):443-6. PubMed ID: 1659048
[TBL] [Abstract][Full Text] [Related]
37. CMV prophylaxis in allogeneic BMT with ganciclovir and CMV immune globulin.
Patton WN; Carter C; Bienz N; Lamb T; Boughton BJ; Franklin IM
Bone Marrow Transplant; 1991; 7 Suppl 2():44. PubMed ID: 1652330
[No Abstract] [Full Text] [Related]
38. Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation.
Elfenbein G; Krischer J; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
Transplant Proc; 1989 Feb; 21(1 Pt 3):3099-100. PubMed ID: 2539688
[No Abstract] [Full Text] [Related]
39. Prevention of CMV infection after BMT in high-risk patients using CMV hyperimmune globulin.
Einsele H; Vallbracht A; Schmidt H; Friese M; Schüch K; Haen M; Dopfer R; Niethammer D; Waller HD; Ehninger G
Cancer Detect Prev; 1988; 12(1-6):637-41. PubMed ID: 2846173
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of immune globulin in preventing complications of bone marrow transplantation: a meta-analysis.
Bass EB; Powe NR; Goodman SN; Graziano SL; Griffiths RI; Kickler TS; Wingard JR
Bone Marrow Transplant; 1993 Sep; 12(3):273-82. PubMed ID: 8241987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
